Serologic Survey of IgG Against SARS-CoV-2 Among Hospital Visitors Without a History of SARS-CoV-2 Infection in Tokyo, 2020–2021

BACKGROUND: Tokyo, the capital of Japan, is a densely populated city of >13 million people, so the population is at high risk of epidemic severe acute respiratory coronavirus 2 (SARS-CoV-2) infection. A serologic survey of anti–SARS-CoV-2 IgG would provide valuable data for assessing the city’s S...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanada, Takahiro, Honda, Tomoko, Yasui, Fumihiko, Yamaji, Kenzaburo, Munakata, Tsubasa, Yamamoto, Naoki, Kurano, Makoto, Matsumoto, Yusuke, Kohno, Risa, Toyama, Sakiko, Kishi, Yoshiro, Horibe, Takuro, Kaneko, Yudai, Kakegawa, Mayumi, Fukui, Kazushige, Kawamura, Takeshi, Daming, Wang, Qian, Chungen, Xia, Fuzhen, He, Fan, Yamasaki, Syudo, Nishida, Atsushi, Harada, Takayuki, Higa, Masahiko, Tokunaga, Yuko, Takagi, Asako, Itokawa, Masanari, Kodama, Tatsuhiko, Kohara, Michinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761565/
https://www.ncbi.nlm.nih.gov/pubmed/34776499
http://dx.doi.org/10.2188/jea.JE20210324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761565/
https://www.ncbi.nlm.nih.gov/pubmed/34776499
http://dx.doi.org/10.2188/jea.JE20210324

Ejemplares similares